Elixxer Ltd.
ELIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 112.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | 96.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $2 | $2 |
| SG&A Expenses | $0 | $0 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | $0 | $0 | -$2 | $0 |
| Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Income | -$0 | -$0 | $0 | -$1 |
| % Margin | – | – | 0% | -3,909.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$13 | -$1 |
| Pre-Tax Income | -$0 | -$0 | -$14 | -$2 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$0 | -$0 | -$14 | -$2 |
| % Margin | – | – | -21,169.1% | -6,827.6% |
| EPS | -0 | -0 | -1.27 | -0.245 |
| % Growth | 0% | 100% | -419.2% | – |
| EPS Diluted | -0 | -0 | -1.27 | -0.245 |
| Weighted Avg Shares Out | 11 | 11 | 11 | 9 |
| Weighted Avg Shares Out Dil | 11 | 11 | 11 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $2 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$12 | -$1 |
| % Margin | – | – | -17,385.3% | -3,905.8% |